Mindy L. Hartgers

Prognostic factors and benefits of adjuvant therapy after pancreatoduodenectomy for ampullary adenocarcinoma: Mayo Clinic experience

Zhaohui Jin, Mindy L. Hartgers, Cristobal T. Sanhueza et al. · European Journal of Surgical Oncology · 2018 · 54 citations

Prognostic Factors, Surgical Oncology, Pancreatic Cancer +7

Bolus 5-fluorouracil (5-FU) In Combination With Oxaliplatin Is Safe and Well Tolerated in Patients Who Experienced Coronary Vasospasm With Infusional 5-FU or Capecitabine

Sakti Chakrabarti, Jaskanwal Deep Singh Sara, Ronstan Lobo et al. · Clinical Colorectal Cancer · 2018 · 40 citations

Infusional 5-Fu, Cardiovascular Disease, Medicine +6

Importance of Device Evaluation for Point-of-Care Prothrombin Time International Normalized Ratio Testing Programs

Robert D. McBane, Cindy L. Felty, Mindy L. Hartgers et al. · Mayo Clinic Proceedings · 2005 · 39 citations

Thrombosis, Point-of-care Testing, Diagnostic Device +10

Malignant transformation of biliary adenofibroma: a rare biliary cystic tumor

Scott M. Thompson, Benjamin Zendejas-Mummert, Mindy L. Hartgers et al. · Journal of Gastrointestinal Oncology · 2016 · 25 citations · Full text

Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma

Sakti Chakrabarti, Tyler Zemla, Daniel H. Ahn et al. · The Oncologist · 2019 · 12 citations · Full text